Project Grant R03DE036061
- Federal Grant Award Summary The University of Texas Health Science Center at Houston received a $578,830 Project Grant awarded May 15, 2026, from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121). The award supports development and validation of PREDICT (Periodontitis Recognition and Estimation Using Diagnostic Intelligence & Computational Techniques), an artificial intelligence-driven clinical decision...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded the University of Texas Health Science Center at Houston a Project Grant of $721,776 on July 6, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to establish the OpenMouth initiative. This project delivers two primary products: (1) a fully de-identified and governance-enabled version of the BigMouth Dental Data Repository—the largest clinical dental big data resource...
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded $584,420 to the University of Michigan (Regents of the University of Michigan) under the Oral Diseases and Disorders Research program (CFDA 93.121) effective May 1, 2026, through April 30, 2030. This Project Grant supports research to decipher the cellular and genetic mechanisms underlying osteonecrosis of the jaw (ONJ), a serious condition characterized by exposed and necrotic bone...
- Federal Grant Award Summary The University of Texas Health Science Center at San Antonio received a $1,950,638 Project Grant from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), awarded August 13, 2025, with completion targeted for May 31, 2029. The research addresses pain management in head and neck carcinoma patients by investigating the role of the truncated TrkB tyrosine kinase receptor isoform...
- Federal Grant Award Summary The University of Florida, Division of Sponsored Research, received a $428,188 Project Grant award dated July 9, 2026, from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121). The two-year project, concluding July 8, 2028, will deliver research and development services focused on preventing and treating medication-related osteonecrosis of the jaw (MRONJ), a serious condition affecting...
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $315,000 Project Grant to The University of Texas Health Science Center at San Antonio effective August 20, 2025, through August 19, 2027, under the Oral Diseases and Disorders Research program (CFDA 93.121). This award supports research to develop and validate a novel therapeutic approach targeting Transient Receptor Potential Canonical 1 (TRPC1) channels as a treatment for oral...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded the University of Maryland, Baltimore a Project Grant totaling $427,625 under the Oral Diseases and Disorders Research program (CFDA 93.121) for the period July 1, 2025 through June 30, 2027. This research project will investigate the causal relationship between denosumab (DMAB) therapy and multiple external cervical root resorption (MECRR), a pathological condition affecting permanent teeth....
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded The University of Texas Health Science Center at San Antonio $449,861 under the Oral Diseases and Disorders Research program (CFDA 93.121) to conduct a 24-month clinical observational feasibility study examining dental practitioners' oral appliance therapy (OAT) titration methods for obstructive sleep apnea (OSA) and their associated patient outcomes. Initiated on June 17, 2025, the...
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $1.47 million Project Grant to the University of Texas MD Anderson Cancer Center on March 1, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121). The five-year award, extending through February 28, 2031, supports research to elucidate subclonal evolution and fitness dynamics in oral carcinogenesis. The project addresses the significant clinical challenge that...
- Federal Grant Award Summary The University of Florida received a $639,248 Project Grant from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), awarded June 1, 2025, with completion scheduled for May 31, 2027. This award supports statistical methodology development and secondary analysis of the National Health and Nutrition Examination Survey (NHANES) to assess person-level marginal associations between...
The University of Texas Medical Branch at Galveston received a $323,000 Project Grant award dated July 9, 2026, from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121). The grant supports a two-year research initiative (through July 8, 2028) focused on modeling causal mediation by dental care and developing risk prediction tools for osteonecrosis of the jaw (ONJ) in bisphosphonate users. The project addresses a critical clinical gap by establishing rigorous methodological frameworks to understand how specific dental interventions causally modify ONJ risk—a serious adverse event that complicates the treatment of osteoporosis and cancer-related bone metastases in older adults with multiple comorbidities. The deliverables include development of advanced statistical mediation models that account for time-varying bisphosphonate exposure, time-dependent dental care interventions, competing risk of mortality, and the time-to-event nature of ONJ onset. Additionally, the project will generate validated dynamic prognostic models incorporating time-varying risk factors to translate research findings into actionable clinical decision-support tools. These methodological and predictive outputs are designed to enable evidence-based clinical decision-making regarding whether, when, and how specific dental interventions should be prioritized or modified during bisphosphonate therapy, thereby bridging the gap between current observational clinical guidelines and causal scientific evidence.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $323.0k | 7/10/26 |